ALG9 Gene Glycosylation Disorder Type 1L Genetic Test
Welcome to DNA Labs UAE, where we offer the ALG9 Gene Glycosylation Disorder Type 1L Genetic Test. This test is designed to identify mutations or alterations in the ALG9 gene that may be causing glycosylation disorder type 1L. Read on to learn more about this test, including its components, cost, symptoms, diagnosis, and more.
Test Details
The ALG9 gene is responsible for encoding an enzyme called alpha-1,2-mannosyltransferase, which plays a crucial role in the glycosylation process. Glycosylation is the process of attaching sugar molecules to proteins or lipids, which is essential for their proper functioning. In the case of glycosylation disorder type 1L, there is a specific mutation or alteration in the ALG9 gene, leading to a dysfunction in the alpha-1,2-mannosyltransferase enzyme. This dysfunction can result in abnormal glycosylation patterns and various health problems.
Test Components and Price
- Test Name: ALG9 Gene Glycosylation Disorder Type 1L Genetic Test
- Price: 4400.0 AED
Sample Condition
We accept the following sample types for this test:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
The report for the ALG9 Gene Glycosylation Disorder Type 1L Genetic Test will be delivered within 3 to 4 weeks.
Test Method
We utilize NGS (Next-Generation Sequencing) technology for this genetic test. NGS allows us to analyze and sequence the DNA of an individual efficiently and accurately.
Test Type
The ALG9 Gene Glycosylation Disorder Type 1L Genetic Test falls under the category of metabolic disorders.
Referring Doctor
Our test can be requested by a general physician or any other healthcare professional.
Test Department
This test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the ALG9 Gene Glycosylation Disorder Type 1L NGS Genetic DNA Test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with Glycosylation disorder type 1L.
Conclusion
The ALG9 Gene Glycosylation Disorder Type 1L Genetic Test offered at DNA Labs UAE is a valuable tool for diagnosing individuals with this specific glycosylation disorder. By identifying mutations or alterations in the ALG9 gene, this test provides crucial information for managing the condition and developing potential treatment options. If you suspect that you or a family member may have glycosylation disorder type 1L, we encourage you to consult with a healthcare professional and consider our genetic test.
Test Name | ALG9 Gene Glycosylation disorder type 1L Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ALG9 Gene Glycosylation disorder type 1L NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1L |
Test Details |
The ALG9 gene is responsible for encoding an enzyme called alpha-1,2-mannosyltransferase, which is involved in the glycosylation process. Glycosylation is the process of attaching sugar molecules to proteins or lipids, which is essential for their proper functioning. A glycosylation disorder type 1L refers to a specific mutation or alteration in the ALG9 gene that leads to a dysfunction in the alpha-1,2-mannosyltransferase enzyme. This dysfunction can result in abnormal glycosylation patterns and lead to various health problems. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze and sequence the DNA of an individual. In the context of ALG9 gene glycosylation disorder type 1L, NGS genetic testing can be used to identify mutations or alterations in the ALG9 gene that may be causing the glycosylation disorder. By identifying specific mutations or alterations in the ALG9 gene, NGS genetic testing can help diagnose individuals with ALG9 gene glycosylation disorder type 1L and provide valuable information for managing their condition and developing potential treatment options. |